Hyperglycemic crises resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
* [[Insulin pump|Failure of pump therapy]]<ref name="Rosenbloom-2010">{{Cite journal | last1 = Rosenbloom | first1 = AL. | title = The management of diabetic ketoacidosis in children. | journal = Diabetes Ther | volume = 1 | issue = 2 | pages = 103-20 | month = Dec | year = 2010 | doi = 10.1007/s13300-010-0008-2 | PMID = 22127748 }}</ref><ref name="Baird-2009">{{Cite journal | last1 = Baird | first1 = JS. | title = Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report. | journal = Cases J | volume = 2 | issue = | pages = 8012 | month = | year = 2009 | doi = 10.4076/1757-1626-2-8012 | PMID = 19918445 }}</ref>
* [[Insulin pump|Failure of pump therapy]]<ref name="Rosenbloom-2010">{{Cite journal | last1 = Rosenbloom | first1 = AL. | title = The management of diabetic ketoacidosis in children. | journal = Diabetes Ther | volume = 1 | issue = 2 | pages = 103-20 | month = Dec | year = 2010 | doi = 10.1007/s13300-010-0008-2 | PMID = 22127748 }}</ref><ref name="Baird-2009">{{Cite journal | last1 = Baird | first1 = JS. | title = Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report. | journal = Cases J | volume = 2 | issue = | pages = 8012 | month = | year = 2009 | doi = 10.4076/1757-1626-2-8012 | PMID = 19918445 }}</ref>
* [[Infections]] ([[UTI]], [[pneumonia]]) <ref name="Umpierrez-2003">{{Cite journal | last1 = Umpierrez | first1 = GE. | last2 = Kitabchi | first2 = AE. | title = Diabetic ketoacidosis: risk factors and management strategies. | journal = Treat Endocrinol | volume = 2 | issue = 2 | pages = 95-108 | month = | year = 2003 | doi = | PMID = 15871546 }}</ref>
* [[Infections]] ([[UTI]], [[pneumonia]]) <ref name="Umpierrez-2003">{{Cite journal | last1 = Umpierrez | first1 = GE. | last2 = Kitabchi | first2 = AE. | title = Diabetic ketoacidosis: risk factors and management strategies. | journal = Treat Endocrinol | volume = 2 | issue = 2 | pages = 95-108 | month = | year = 2003 | doi = | PMID = 15871546 }}</ref>
* Intoxication (Drugs & alcohol)
* [[Medications]] ([[corticosteroid]], [[pentamidine]],<ref name="Lambertus-1988">{{Cite journal | last1 = Lambertus | first1 = MW. | last2 = Murthy | first2 = AR. | last3 = Nagami | first3 = P. | last4 = Goetz | first4 = MB. | title = Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome. | journal = West J Med | volume = 149 | issue = 5 | pages = 602-4 | month = Nov | year = 1988 | doi = | PMID = 3150636 }}</ref> [[clozapine]]) <ref name="Ai-1998">{{Cite journal | last1 = Ai | first1 = D. | last2 = Roper | first2 = TA. | last3 = Riley | first3 = JA. | title = Diabetic ketoacidosis and clozapine. | journal = Postgrad Med J | volume = 74 | issue = 874 | pages = 493-4 | month = Aug | year = 1998 | doi = | PMID = 9926128 }}</ref>
* [[Medications]] ([[corticosteroid]], [[pentamidine]],<ref name="Lambertus-1988">{{Cite journal | last1 = Lambertus | first1 = MW. | last2 = Murthy | first2 = AR. | last3 = Nagami | first3 = P. | last4 = Goetz | first4 = MB. | title = Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome. | journal = West J Med | volume = 149 | issue = 5 | pages = 602-4 | month = Nov | year = 1988 | doi = | PMID = 3150636 }}</ref> [[clozapine]]) <ref name="Ai-1998">{{Cite journal | last1 = Ai | first1 = D. | last2 = Roper | first2 = TA. | last3 = Riley | first3 = JA. | title = Diabetic ketoacidosis and clozapine. | journal = Postgrad Med J | volume = 74 | issue = 874 | pages = 493-4 | month = Aug | year = 1998 | doi = | PMID = 9926128 }}</ref>
* [[MI]]
* [[MI]]

Revision as of 17:44, 4 December 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]

Definition

Diabetic ketoacidosis is a life threatening complication of untreated or inadequately treated diabetes mellitus and is characterized by hyperglycemia, acidosis and elevated ketone levels.

Causes

Life Threatening Causes

Diabetic ketoacidosis is a life-threatening condition and must be treated as such irrespective of the causes. Life-threatening conditions may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diabetic ketoacidosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H/O suggestive of DKA: Vomiting, abdominal pain, drowsiness,
altered mentation, fever, malaise
Precipitating factors:
Insulin deficiency, infections, stress,
MI, pregnancy, new onset DM type 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check labs
CBC, Chem 7, ABG, EKG,
CXR, urine dipstick & routine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic criteria
Blood glucose > 250 mg/dL
pH < 7.3
Serum bicarbonate < 18 mEq/L
Serum ketones (+)
Anion gap > 10
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV fluid therapy
 
 
 
 
 
 
 
Insulin
 
 
 
 
 
 
 
Need for K+ replacement?
 
 
 
 
 
 
 
Need for bicarbonate replacement?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check hydration status
 
 
 
 
 
IV
 
SC for uncomplicated DKA
 
<3.3 mEq/dL
 
3.3-5.3 mEq/dL
 
>5.3 mEq/dL
 
pH < 6.9
 
pH > 7.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild dehydration
 
Severe dehydration
 
Cardiogenic shock
 
Regular insulin (0.1 U/kg) bolus
 
Rapid action insulin 0.3 U/kg then 0.2 U/kg after 1 hr
 
Hold insulin, supplement K+ (20-30 mEq/hr) till K+ > 3.3 mEq/L
 
Administer 20-30 mEq/L K+
 
Don't supplement, check 2 hourly
 
Dilute NaHCo3 (100 mmol) in 400 ml H2O with 20 mEq KCl infused over 2 hrs
 
No bicarbonate needed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate for corrected Na+ levels
 
Start 0.9% NaCl (1L/hr) initially
 
Pressors/ Monitor hemodynamics
 
Continuous infusion (0.1 U/kg/hr)
 
SC insulin 0.2 U/kg every 2 hrs
 
 
 
 
 
 
 
 
 
 
 
 
 
Recheck
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High Na+ levels
 
Normal Na+ levels
 
Low Na+ levels
 
 
 
 
 
 
 
Double insulin infusion if blood sugar doesn't fall by 50-70 mg/dL in first hr
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Switch to 0.45% NaCl (250-500mL/hr)
 
 
 
Continue to 0.9% NaCl (250-500mL/hr)
 
 
 
 
 
 
 
At serum glucose = 200 mg/dL reduce IV insulin to 0.02-0.05 U/kg/hr or SC insulin (0.1 U/kg) every 2 hrs
Target blood sugar to 150-200 mg/dL till DKA resolves
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check blood glucose levels
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At serum glucose levels ~ 200 mg/dL
Switch to 5% dextrose with 0.45% NaCl (150-250 ml/hr)
 
 
 
 
 
 
 
 
 
 
Check labs every 2-4 hrs

Transition to SC insulin (0.8 U/kg/day) when pt tolerates oral feeding

Stop IV insulin gradually.
Monitor for complications:
Hypogylcemia, hypokalemia, cerebral edema, respiratory distress, sepsis, acute gastric dilation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Adapted from the recommendations given by American Diabetes Association (ASA) and other sources.[8]

Do's

  • Check labs initially and every 2-4 hours.
  • Immediately check urine for ketones with dipstick and send urine to the lab for analysis.
  • Initiate IV insulin as soon as the patient arrives and satisfies the diagnostic criteria of DKA.
  • Assess the trigger that precipitated DKA and treat the cause.
  • Admit the patient to the floor; however, if the pH < 7.0 or the patient is unconscious then admit to ICU.
  • Assess the hydration status and treat it aggressively as needed.
  • Switch to dextrose with normal saline once the blood sugar falls to 200 mg/dL.
  • Monitor for complications of DKA itself or of the therapy.

Don'ts

  • Do not stop IV insulin until DKA has resolved.
  • Do not stop IV insulin, even if SC insulin is administered because it needs time to kick in.
  • Do not give insulin if K+ levels are below 3.5 mEq/l because it may further exacerbate the hypokalemia.
  • Do not use 0.9% NaCl if corrected Na+ levels > 145 mEq/l, use 0.45% instead.
  • Do not supplement phosphate excessively, clinical trials have not shown any benefits. Give only if there is an actual deficiency.

References

  1. Rosenbloom, AL. (2010). "The management of diabetic ketoacidosis in children". Diabetes Ther. 1 (2): 103–20. doi:10.1007/s13300-010-0008-2. PMID 22127748. Unknown parameter |month= ignored (help)
  2. Baird, JS. (2009). "Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report". Cases J. 2: 8012. doi:10.4076/1757-1626-2-8012. PMID 19918445.
  3. Umpierrez, GE.; Kitabchi, AE. (2003). "Diabetic ketoacidosis: risk factors and management strategies". Treat Endocrinol. 2 (2): 95–108. PMID 15871546.
  4. Lambertus, MW.; Murthy, AR.; Nagami, P.; Goetz, MB. (1988). "Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome". West J Med. 149 (5): 602–4. PMID 3150636. Unknown parameter |month= ignored (help)
  5. Ai, D.; Roper, TA.; Riley, JA. (1998). "Diabetic ketoacidosis and clozapine". Postgrad Med J. 74 (874): 493–4. PMID 9926128. Unknown parameter |month= ignored (help)
  6. Parker, JA.; Conway, DL. (2007). "Diabetic ketoacidosis in pregnancy". Obstet Gynecol Clin North Am. 34 (3): 533–43, xii. doi:10.1016/j.ogc.2007.08.001. PMID 17921013. Unknown parameter |month= ignored (help)
  7. MacGillivray, MH.; Bruck, E.; Voorhess, ML. (1981). "Acute diabetic ketoacidosis in children: role of the stress hormones". Pediatr Res. 15 (2): 99–106. doi:10.1203/00006450-198102000-00002. PMID 6789292. Unknown parameter |month= ignored (help)
  8. Nyenwe, EA.; Kitabchi, AE. (2011). "Evidence-based management of hyperglycemic emergencies in diabetes mellitus". Diabetes Res Clin Pract. 94 (3): 340–51. doi:10.1016/j.diabres.2011.09.012. PMID 21978840. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources